Split History
ETFs Holding SCYX »    SCYX Historical Stock Prices »

Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
SCYNEXIS is a biotechnology company. Co. is developing its main product candidate, ibrexafungerp, as an intravenous/oral agent for multiple fungal indications in both the community and hospital settings. The U.S. Food and Drug Administration has approved BREXAFEMME (ibrexafungerp tablets) for treatment of patients with vulvovaginal candidiasis, also known as vaginal yeast infection, and for the reduction in the incidence of recurrent vulvovaginal candidiasis, respectively. Co. is also continuing on-going clinical studies of ibrexafungerp for multiple indications, including the treatment of life-threatening invasive fungal infections in hospitalized patients. According to our SCYX split history records, SCYNEXIS has had 1 split.
SCYX split history picture
SCYNEXIS (SCYX) has 1 split in our SCYX split history database. The split for SCYX took place on July 17, 2020. This was a 1 for 10 reverse split, meaning for each 10 shares of SCYX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as SCYNEXIS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the SCYX split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SCYNEXIS shares, starting with a $10,000 purchase of SCYX, presented on a split-history-adjusted basis factoring in the complete SCYX split history. SCYX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/25/2014
End date: 06/21/2024
Start price/share: $81.00
End price/share: $1.95
Dividends collected/share: $0.00
Total return: -97.59%
Average Annual Total Return: -31.12%
Starting investment: $10,000.00
Ending investment: $240.64
Years: 10.00
Date Ratio
07/17/20201 for 10
SCYX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

SELB Split History
SEM Split History
SGNL Split History
SGYP Split History
SIEN Split History
SKBI Split History
SKLN Split History
SLNO Split History
SLS Split History
SLXP Split History

Also explore: SCYX shares outstanding history

Email EnvelopeFree SCYX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Crown Electrokinetics Corp. (CRKN)
Medalist Diversified REIT, Inc. (MDRR)
Medalist Diversified REIT, Inc. (MDRR)
Qilian International Holding Group Limited (QLI)
Bluejay Diagnostics, Inc. (BJDX)
Atara Biotherapeutics, Inc. (ATRA)
GRI Bio, Inc. (GRI)
Williams-Sonoma, Inc. (WSM)
Workhorse Group Inc. (WKHS)
Virgin Galactic Holdings, Inc. (SPCE)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

SCYX Insider Buying

SCYX Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.